Ad image

Tag: Agonist

Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist By Investing.com

Seoul, South Korea, August 27, 2024 /PRNewswire/ -- Unovia is Ildong Pharmaceutical…

KunstJagd KunstJagd